The institutional landscape for Gain Therapeutics, Inc. (NASDAQ:GANX) includes 45 filers as of the latest reporting cycle ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| MARSHALL WACE, LLP | 31 Dec, 2025 | 1,662,293 | 1,487,186 | 849.30% | $5,352,582.00 |
| Potomac Capital Management, Inc. | 31 Dec, 2025 | 1,010,000 | 1,010,000 | 0.00% | $3,252,200.00 |
| JONES FINANCIAL COMPANIES LLLP | 31 Dec, 2025 | 702,213 | 25,391 | 3.75% | $2,261,126.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 684,349 | 603,914 | 750.81% | $2,203,604.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 569,901 | 35,549 | 6.65% | $1,835,082.00 |
| Cambridge Investment Research Advisors, Inc. | 31 Dec, 2025 | 568,645 | 250,000 | 78.46% | $1,831.00 |
| DME Capital Management, LP | 31 Dec, 2025 | 566,130 | 0 | 0.00% | $1,822,939.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 397,942 | 53,796 | 15.63% | $1,282,455.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 242,328 | 169,878 | 234.48% | $780,296.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 209,579 | 93,395 | 80.39% | $674,844.00 |
| Cresset Asset Management, LLC | 31 Dec, 2025 | 160,000 | 160,000 | 0.00% | $515,200.00 |
| STATE STREET CORP | 31 Dec, 2025 | 157,537 | 66,400 | 72.86% | $507,269.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 147,591 | -8,084 | -5.19% | $475,244.00 |
| LPL Financial LLC | 31 Dec, 2025 | 106,550 | 106,550 | 0.00% | $343,091.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 102,001 | 13,602 | 15.39% | $328,443.00 |
| UBS Group AG | 31 Dec, 2025 | 81,121 | -59,556 | -42.34% | $261,210.00 |
| Focus Partners Wealth | 31 Dec, 2025 | 77,855 | 77,855 | 0.00% | $250,693.00 |
| HRT FINANCIAL LP | 31 Dec, 2025 | 55,679 | 35,962 | 182.39% | $179.00 |
| GROUP ONE TRADING LLC | 31 Dec, 2025 | 54,159 | 37,384 | 222.86% | $174,392.00 |
| SIMPLEX TRADING, LLC | 31 Dec, 2025 | 47,946 | 47,946 | 0.00% | $154,386.00 |